Achilles Therapeutics PLC (ACHL) is higher by Wednesday morning, with the stock adding 1.61% in pre-market trading to 1.26.
ACHL's short-term technical score of 52 indicates that the stock has traded more bullishly over the last month than 52% of stocks on the market. In the Biotechnology industry, which ranks 100 out of 146 industries, ACHL ranks higher than 67% of stocks.
Achilles Therapeutics PLC has fallen 8.82% over the past month, closing at $1.57 on February 28. During this period of time, the stock fell as low as $1.10 and as high as $1.76. ACHL has an average analyst recommendation of Buy. The company has an average price target of $6.50.
ACHL has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on ACHL!
Achilles Therapeutics PLC has a Long-Term Technical rank of 85. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 15% of the market scoring higher. In the Biotechnology industry which is number 69 by this metric, ACHL ranks better than 69% of stocks.
